Results 151 to 160 of about 7,461 (205)

Genetic polymorphism of CYP2C19, CYP2C9 and VKORC1 in Kosovo population [Genetički polimiorfizam CYP2C19, CYP2C9 i VKORC1 u kosovskoj populaciji]

open access: yes, 2017
Background: For the first time, we determined and analyzed frequency of the most important variant alleles of CYP2C9, CYP2C19, CYP3A5 and VKORC1 in Kosovo‟s population. Methods: Determination of genetic polymorphism was conducted in 234 nonrelated Kosovars and genotyping was conducted by Real-Time PCR. Results: Allele frequencies of CYP 2C9*2 and 2C9*3
openaire   +1 more source

Design and validation of a clinical whole genome sequencing-based assay for patient screening in a large healthcare system. [PDF]

open access: yesFront Mol Biosci
Wagner JT   +16 more
europepmc   +1 more source

GENOTIPIZACIJA VKORC1, CYP4F2, CYP2C9 NA VZORCU SPLOŠNE POPULACIJE

open access: yes, 2012
Namen diplomske naloge je določiti genotipe specifičnih enonukleotidnih polimorfizmov tarčnih genov, ki so odgovorni za višji ali nižji začetni odmerek varfarina. To so VKORC1-1639G>A, CYP2C92-430C>T, CYP2C93-1075A>C, CYP4F2-132C>T. Varfarin je učinkovina, oralni antikoagulant, ki se predpisuje bolnikom z pljučno embolijo, globoko vensko trombozo ...
openaire   +1 more source

Recommendations for (Pharmaco)Genetic Sampling in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation. [PDF]

open access: yesClin Transl Sci
Bokma A   +8 more
europepmc   +1 more source

Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy. [PDF]

open access: yesSci Rep
Huang D   +10 more
europepmc   +1 more source

An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate. [PDF]

open access: yesDrugs R D
Murrell DE   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy